Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDERSHOP NOW →

GLP-3/RT vs Glutathione

GLP-3/RT and Glutathione are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Metabolic
ClassLipidated single-chain triple receptor agonist (GIP / GLP-1 / glucagon)Endogenous thiol tripeptide (γ-L-glutamyl-L-cysteinyl-glycine), reduced form
Molecular weight4759.5 g/mol307.3 g/mol
CAS numberNot assigned / not specified70-18-8
Purity spec≥99%≥99%
Research areasMetabolicCellular Longevity, Metabolic
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Sterile water (USP grade)
Working windowCommonly worked with for 4–6 weeks at 2–8 °C.Commonly worked with for about 1 week at 2-8 °C; frozen aliquots keep longer.
Lead degradation routeInterfacial aggregation from agitation, foaming, or freeze–thaw — the primary practical failure mode for this molecule class.Oxidation of the cysteine thiol to glutathione disulfide (GSSG, about 612.6 Da), catalysed by trace Cu²⁺/Fe³⁺ and faster at neutral-to-alkaline pH.
Freeze–thawAvoid freezing reconstituted material. For lipidated peptides the freeze–thaw risk is aggregation at the ice–liquid interface rather than chemical breakdown, and aggregation is not reversible on rewarming.Tolerates a few freeze-thaw cycles, but each thaw exposes the thiol to dissolved oxygen. Aliquot once and thaw each portion only once.
Light sensitivityNo specific light requirement beyond normal practice.Not strongly light-sensitive, but oxygen-sensitive: minimise headspace and avoid metal spatulas or metal-contaminated buffers.

How they actually differ

Comparing the two: GLP-3/RT is lipidated single-chain triple receptor agonist (gip / glp-1 / glucagon), while Glutathione is endogenous thiol tripeptide (γ-l-glutamyl-l-cysteinyl-glycine), reduced form — different molecular classes with different handling consequences; they call for different primary diluents (bacteriostatic water (0.9% benzyl alcohol) versus sterile water (usp grade)); their leading degradation routes differ (interfacial aggregation from agitation, foaming, or freeze–thaw for GLP-3/RT, oxidation of the cysteine thiol to glutathione disulfide (gssg, about 612.6 da), catalysed by trace cu²⁺/fe³⁺ and faster at neutral-to-alkaline ph. for Glutathione), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

GLP-3/RT — origin

GLP-3/RT is a rationally engineered single peptide chain designed to activate three receptors at once — GIP, GLP-1, and glucagon. It represents the third generation of incretin design: mono-agonists first, dual agonists such as GLP-2/Tirz second, and triagonists third. Adding glucagon-receptor activity is the conceptual leap, since glucagon signalling contributes energy expenditure rather than only appetite and glycaemic effects.

Glutathione — origin

Glutathione is the tripeptide γ-glutamyl-cysteinyl-glycine. The glutamate is joined through its side-chain (γ) carboxyl rather than the usual α link, which protects it from most peptidases. It was named by Frederick Gowland Hopkins in 1921, and its role in cellular redox chemistry was mapped out through the 20th century, most influentially in Alton Meister's work on the γ-glutamyl cycle.

GLP-3/RT research themes

Triple receptor engagement

The defining feature: simultaneous GIP, GLP-1, and glucagon receptor activity from one chain.

Energy expenditure

Glucagon-receptor activity is studied for its contribution to energy expenditure, distinguishing triagonists from dual agonists.

Glucose regulation

Investigated in metabolic research models for effects on glucose homeostasis.

Body composition in research models

A major focus of the preclinical literature on this compound class.

Glutathione research themes

Cellular redox buffering (GSH/GSSG ratio)

Glutathione is the most abundant low-molecular-weight thiol in most cells, and the ratio of reduced to oxidised glutathione is widely used as a read-out of oxidative stress in cell-culture and tissue studies.

The γ-glutamyl cycle

Meister and Anderson (Annu Rev Biochem 1983) reviewed glutathione synthesis by γ-glutamylcysteine synthetase and glutathione synthetase, and its breakdown by γ-glutamyl transpeptidase — the framework most synthesis and turnover studies still use.

Detoxification by glutathione S-transferases

GSTs conjugate glutathione to electrophilic compounds, and this conjugation step is a standard model in xenobiotic-metabolism research.

The glutathione peroxidase system

Glutathione peroxidases use GSH to reduce hydrogen peroxide and lipid hydroperoxides, with glutathione reductase recycling GSSG back to GSH using NADPH — a common model for studying peroxide handling in vitro.

GLP-3/RT handling

  • Never shake. Foam on a lipidated peptide solution is denatured material at the air–liquid interface, not a cosmetic issue.
  • Introduce diluent slowly down the vial wall and allow the cake to dissolve without agitation, which may take several minutes.
  • Do not freeze reconstituted solution — aggregation from freeze–thaw is irreversible.
  • Faint opalescence at high concentration is expected; visible particulate is not.

Glutathione handling

  • Let the vial reach room temperature before opening to stop condensation getting in.
  • Use degassed diluent where possible and cap promptly after drawing.
  • Avoid metal tools and buffers with trace copper or iron; plastic or glass only.
  • Label aliquots with reconstitution date and diluent.

Both third-party tested

Every Popular Peptides batch of GLP-3/RT and Glutathione is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

GLP-3/RT reference

Glutathione reference

Related comparisons

GLP-3/RT and Glutathione are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.